Bickerstaff brainstem encephalitis associated with Chikungunya infection: A case report
DOI:
https://doi.org/10.61997/bjm.v14i1.451Keywords:
Guillain-Barre Syndrome, Miller Fisher Syndrome, Autoimmune diseases, Brainstem encephalitis, EncephalitisAbstract
Introduction: Bickerstaff brainstem encephalitis is a rare autoimmune disease that presents certain similarities with other demyelinating neuropathies. The classic diagnostic triad includes ophthalmoplegia, ataxia and/or pyramidal symptoms. The global prevalence is unknown, and it is associated with an immune reaction triggered by a viral or bacterial infection or recent immunization. Clinical case: The case of a 57-year-old female patient with a four-week history of Chikungunya is presented. Current three-day history of weakness in the lower and upper extremities, tingling sensation in the lower extremities, left facial paralysis, ocular deviation, and right lateralized corner of the mouth. Neurological examination: conscious, left peripheral facial paralysis, bilateral facial hypoesthesia, dysarthria, difficulty smiling, blowing, whistling and swallowing, paresis of eye movements, bilateral eyelid ptosis, decreased visual acuity, bilateral blurred vision, diplopia, limbs with weakness and lower limb paresthesia; involuntary and uncoordinated rigid movements, tendon areflexia. Magnetic resonance: punctate or amorphous cortico-subcortical hyperdensities. IgM and IgG antibodies were positive for Chikungunya. Treatment with methylprednisolone and complete remission at four months of follow-up. Conclusion: Although etiology is still under discussion, Bickerstaff brainstem encephalitis has been most frequently associated with viral infections, including arboviruses. It must be differentiated by its similarities with Guillain Barré or Miller Fisher syndrome.
Downloads
References
Abide Z, Sif Nasr K, Kaddouri S, Edderai M, Elfenni J, Salaheddine T. Bickerstaff brainstem encephalitis: A case report. Radiol Case Rep. 2023; 18(8):2704-6. doi: 10.1016/j.radcr.2023.04.038 DOI: https://doi.org/10.1016/j.radcr.2023.04.038
Romano N, Federici M, Castaldi A. Imaging Presentation of Bickerstaff Brainstem Encephalitis. Neurohospitalist. 2021; 11(4):370-2. doi: 10.1177/1941874421993671 DOI: https://doi.org/10.1177/1941874421993671
Giaccari LG, Mastria D, Barbieri R, De Maglio R, Madaro F, Paiano G, et al. Bickerstaff encephalitis in childhood: a review of 74 cases in the literature from 1951 to today. Front Neurol. 2024; 15:1387505. doi: 10.3389/fneur.2024.1387505 DOI: https://doi.org/10.3389/fneur.2024.1387505
Messina G, Sciuto S, Fontana A, Greco F, Oliva CF, Pappalardo MG, et al. On clinical findings of Bickerstaff's brainstem encephalitis in childhood. J Integr Neurosci. 2021; 20(2):509-13. doi: 10.31083/j.jin2002054 DOI: https://doi.org/10.31083/j.jin2002054
Pantbalekundri N, Acharya S, Shukla S, Kumar S, Malali S. Bickerstaff's Brainstem Encephalitis and Miller Fisher Syndrome: A Rare Overlap. Cureus. 2024;16(2):e55000. doi: 10.7759/cureus.55000 DOI: https://doi.org/10.7759/cureus.55000
Horton E, Krishnamoorthy S, Reynolds L. Bickerstaff's encephalitis. BMJ Case Rep. 2014; 2014:bcr2014205336. doi: 10.1136/bcr-2014-205336 DOI: https://doi.org/10.1136/bcr-2014-205336
Xue H, Zeng L, He H, Xu D, Ren K. Autoimmune encephalitis in COVID-19 patients: a systematic review of case reports and case series. Front Neurol. 2023; 14:1207883. doi: 10.3389/fneur.2023.1207883 DOI: https://doi.org/10.3389/fneur.2023.1207883
Valencia Sanchez C, Theel E, Binnicker M, Toledano M, McKeon A. Autoimmune Encephalitis After SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes. Neurology. 2021; 97(23):e2262-e8. doi: 10.1212/WNL.0000000000012931 DOI: https://doi.org/10.1212/WNL.0000000000012931
Payus AO, Jeffree MS, Ohn MH, Tan HJ, Ibrahim A, Chia YK, et al. Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19. Neurol Sci. 2022; 43(3):1533-47. doi: 10.1007/s10072-021-05785-z DOI: https://doi.org/10.1007/s10072-021-05785-z
Bagaria AK, Vyas A, Mathur V, Ranawat CS, Singh M. Bickerstaff Brainstem Encephalitis with Isolated Acute Bilateral Ophthalmoplegia: An Unusual Presentation. Ann Indian Acad Neurol. 2021;24(4):624-6. doi: 10.4103/aian.AIAN_823_20 DOI: https://doi.org/10.4103/aian.AIAN_823_20
Michev A, Musso P, Foiadelli T, Trabatti C, Lozza A, Franciotta D, et al. Bickerstaff Brainstem Encephalitis and overlapping Guillain-Barre syndrome in children: Report of two cases and review of the literature. Eur J Paediatr Neurol. 2019;23(1):43-52. doi: 10.1016/j.ejpn.2018.11.008 DOI: https://doi.org/10.1016/j.ejpn.2018.11.008
Orozco E, Valencia-Sanchez C, Britton J, Dubey D, Flanagan E, Lopez-Chiriboga S, et al. Autoimmune Encephalitis Criteria in Clinical Practice. Neurol Clin Pract. 2023;13(3): e200155. doi: 10.1212/CPJ.0000000000200151 DOI: https://doi.org/10.1212/CPJ.0000000000200151
Llorente Ayuso L, Torres Rubio P, Beijinho do Rosario RF, Giganto Arroyo ML, Sierra-Hidalgo F. Bickerstaff encephalitis after COVID-19. J Neurol. 2021;268(6):2035-7. doi: 10.1007/s00415-020-10201-1 DOI: https://doi.org/10.1007/s00415-020-10201-1
Li M, Wang X, Chen M, Chang Y, Li L, Zhong S. A Case Report of Herpes Zoster-Associated Bickerstaff Brainstem Encephalitis. Infect Drug Resist. 2022;15:4759-62. doi: 10.2147/IDR.S374981 DOI: https://doi.org/10.2147/IDR.S374981
Islam M, Cavestro C, Alam S, Kundu S, Kamal M, Reza F. Encephalitis in Patients with COVID-19: A Systematic Evidence-Based Analysis. Cells. 2022;11(2575):1-38. doi: 10.3390/cells11162575 DOI: https://doi.org/10.3390/cells11162575
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Francis Andrea Vásquez Triminio

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
BJM protects Copyright at all times. However, it gives up part of the rights by displaying a Creative Commons License 4.0 (cc-by-nc), which allows the use of the work to share (copy and redistribute the material in any support or format) and adapt (transform and built from the material) as long as exclusive mention of the publication in the journal as the primary source is made. Under no circumstances, the work can be commercialized.